Han Yeon Jae, Jang Yong Jun, Park Geun-Young, Joo Young Hoon, Im Sun
Department of Rehabilitation Medicine, Bucheon St. Mary's Hospital, College of Medicine.
Department of Rehabilitation Medicine, Graduate School.
Medicine (Baltimore). 2020 Feb;99(7):e19220. doi: 10.1097/MD.0000000000019220.
Injection laryngoplasty is a common procedure for patients with vocal fold dysfunction, but the literature on its benefits has been mainly focused on those related to structural lesions or laryngeal nerve involvement. Stroke patients may be at increased risk of aspiration due to insufficient vocal fold motion. However, how injection laryngoplasty can be of benefit in stroke patients has not been reported yet.
Six chronic stroke patients with long-standing swallowing difficulties and who showed severe aspiration despite long-term swallowing rehabilitation.
Laryngoscope evaluation revealed insufficient glottic closure as the cause of aspiration.
Injection laryngoplasty was done per-orally under local anaesthesia with calcium hydroxylapatite (Radiesse Voice, 1-1.5 mL) in an office setting. Respiratory pressures and peak cough flows were assessed at baseline and at 2 weeks follow-up.
At 2 weeks, the mean peak cough flow (Δ = +95.09 L/min) increased significantly after the procedure. The maximal expiratory (Δ = +18.40 cm H2O) and inspiratory (Δ = +20.20 cm H2O) pressures also improved, indicating that injection laryngoplasty was effective in augmenting respiratory and cough parameters. All cases showed improvement in the Functional Oral Intake Scale (Δ = +4). Feeding tubes were successfully removed.
Injection laryngoplasty proved to be both successful and safe in improving glottic closure with immediate results in those who had failed to show a positive response after long-term swallowing rehabilitation. The positive and dramatic clinical outcomes were observed through changes in the coughing force. Our case series support the use of injection larygnoplasty as a powerful adjunctive treatment method to prevent aspiration pneumonia in post-stroke patients with vocal fold insufficiency. Pre- and post-injection peak cough flow changes may reflect improvement in glottic closure and indicate the safety of swallowing with reduced risk of aspiration.
注射式喉成形术是治疗声带功能障碍患者的常用手术,但关于其益处的文献主要集中在与结构病变或喉神经受累相关的方面。中风患者可能因声带运动不足而有更高的误吸风险。然而,注射式喉成形术如何使中风患者受益尚未见报道。
6例慢性中风患者,长期存在吞咽困难,尽管经过长期吞咽康复治疗仍有严重误吸。
喉镜评估显示声门关闭不全是误吸的原因。
在门诊局部麻醉下经口注射羟基磷灰石钙(瑞蓝Voice,1 - 1.5毫升)进行注射式喉成形术。在基线和随访2周时评估呼吸压力和咳嗽峰值流量。
2周时,术后咳嗽峰值流量平均显著增加(Δ = +95.09升/分钟)。最大呼气(Δ = +18.40厘米水柱)和吸气(Δ = +20.20厘米水柱)压力也有所改善,表明注射式喉成形术在增加呼吸和咳嗽参数方面有效。所有病例的功能性经口进食量表均有改善(Δ = +4)。成功拔除了鼻饲管。
注射式喉成形术在改善声门关闭方面被证明是成功且安全的,对于那些长期吞咽康复后无阳性反应的患者能立即取得效果。通过咳嗽力量的变化观察到了积极且显著的临床结果。我们的病例系列支持将注射式喉成形术作为一种有效的辅助治疗方法,用于预防声带功能不全的中风患者发生误吸性肺炎。注射前后咳嗽峰值流量的变化可能反映声门关闭的改善,并表明吞咽安全性提高,误吸风险降低。